Patents by Inventor Tatsuhiko Katori
Tatsuhiko Katori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5324735Abstract: The present invention relates to a quinolone carboxylic acid derivative represented by the following the formula (I), ##STR1## wherein R.sub.1 is a lower alkyl group, R.sub.2 is a hydrogen atom or a lower alkyl group, R.sub.3 is a hydrogen atom or a halogen atom, R.sub.4 and R.sub.5 together form a five- or six-membered ring which may contain hetero atoms or may have substituents, provided that a compound wherein R.sub.1 is a methyl group, R.sub.2 and R.sub.3 are hydrogen atom and ##STR2## is a piperazinyl group is excluded; or a salt thereof; to an antimicrobial agent comprising the same as an effective component; and to an intermediate for producing same.Type: GrantFiled: January 17, 1992Date of Patent: June 28, 1994Assignee: SS Pharmaceutical Co., Ltd.Inventors: Akihiro Shibata, Hideaki Matsuda, Takemitsu Asaoka, Masaru Matsumoto, Ryuichi Kawahara, Tatsuhiko Katori, Naokata Taido, Tadayuki Kuraishi
-
Patent number: 5082948Abstract: Novel imidazole derivatives and their acid adducts are disclosed. The imidazole derivatives are represented by formula: ##STR1## wherein R.sub.1 represents an alkyl group, R.sub.2 represents a hydrogen atom, an alkyl group which may have a substituent, or an aralkyl group which may have a substituent, provided that R.sub.1 and R.sub.2 are not both methyl groups at the same time. They have strong antimicrobial activity, especially against those fungi belonging to the genera Candida, Trichophyton, Microsporum, and Epidermorphyton, as well as against Gram-positive bacteria, and thus is useful as an antimicrobial agent.Type: GrantFiled: February 22, 1990Date of Patent: January 21, 1992Assignee: SS Pharmaceutical Co., Ltd.Inventors: Minoru Tokizawa, Takemitsu Asaoka, Hideaki Matsuda, Tatsuhiko Katori
-
Patent number: 5047428Abstract: An expectorant comprising a hydroxyalkylcysteine derivative of the following formula (I) is disclosed. ##STR1## wherein n represents an integer of 1 to 4. The expectorant is stabile, has little side effects and toxicity, and exhibits an excellent expectorant effect.Type: GrantFiled: June 13, 1989Date of Patent: September 10, 1991Assignee: SS Pharmaceutical Co., Ltd.Inventors: Yoshikuni Itoh, Hiroyuki Mizuno, Chikako Kiyohara, Susumu Sato, Tatsuhiko Katori
-
Patent number: 5008419Abstract: A platinum complex having the following formula (I) is disclosed, ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different and each independently represents a methyl group or an ethyl group, and the configuration of 1,2-diaminocyclohexane is either cis-, trans-l-, trans-d-, or trans-dl-.The compound possess excellent antitumor activity with a high therapeutic index and abundant water solubility, and thus are effective as an antitumor agent.Type: GrantFiled: December 18, 1989Date of Patent: April 16, 1991Assignee: SS Pharmaceutical Co., Ltd.Inventors: Koichi Yokoi, Kazuhiko Irinoda, Hidehiko Kohya, Susumu Sato, Tatsuhiko Katori
-
Patent number: 4977275Abstract: A pyrrole derivative having excellent anti-microbial activities is disclosed. This compound is represented by the following formula (I): ##STR1## wherein X.sub.1 and X.sub.2 are the same or different and mean individually a halogen atom, R.sub.1 denotes an alkyl, cycloalkyl, haloalkyl, alkenyl, substituted or unsubstituted phenyl, substituted or unsubstituted aralkyl group or a group --COR.sub.3 in which R.sub.3 is an alkyl group having at least five carbon atoms or a cycloalkyl, haloalkyl, alkenyl, substituted or unsubstituted phenyl, substituted or unsubstituted aralkyl, or heterocyclic group, and R.sub.2 stands for a hydrogen or halogen atom or an alkyl group, with a proviso that R.sub.1 is other than a hydrogen atom or methyl group when X.sub.1, X.sub.2 and R.sub.2 are each a bromine atom.Type: GrantFiled: April 5, 1989Date of Patent: December 11, 1990Assignee: SS Pharmaceutical Co., Ltd.Inventors: Hiroshi Hasegawa, Kinichi Mogi, Noriaki Shioiri, Susumu Sato, Tatsuhiko Katori
-
Patent number: 4968825Abstract: A platinum complex having a superior antitumor activity is disclosed. The platinum complex has a structure represented by the formula: ##STR1## wherein A and B independently represent a lower alkanoyloxy group which may have a halogen atom substituent, or in combination represent a group: ##STR2## wherein R.sub.1 and R.sub.2 independently represent a hydrogen atom, a hydroxyl group, or a lower alkyl group, or in combination with each other and with the adjacent carbon atom a cyclobutane ring, and R.sub.3 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a halogen atom, a sulfo group, or nitro group.Type: GrantFiled: October 6, 1989Date of Patent: November 6, 1990Assignee: SS Pharmaceutical Co., Ltd.Inventors: Koichi Yokoi, Kinichi Mogi, Kazuhiko Irinoda, Hidehiko Kohya, Susumu Sato, Tatsuhiko Katori
-
Patent number: 4942172Abstract: A method of curing or alleviating hepatic disease comprising administrating to the patient 1,3-dithiole-2-thione or 1,3-dithiolane-2-thione is disclosed. Adminstration of the compound can be made in various dosing forms, including tablets, granules, powders, capsules, suspensions, injections, and suppositories. Normal dosing amount can be determined from the range of 0.01 to 50 mg/kg/day for oral administration, and 0.002 to 10 mg/kg/day for injection or other forms of administration.Type: GrantFiled: May 20, 1988Date of Patent: July 17, 1990Assignee: SS Pharmaceutical Co., Ltd.Inventors: Hitoshi Nakazawa, Mari Ohtsuka, Hideaki Matsuda, Tatsuhiko Katori, Kazuhiko Irinoda
-
Patent number: 4933447Abstract: A quinoline derivative represented by the following formula is disclosed. ##STR1## wherein R.sub.1 represents a hydrogen atom or an alkyl group which may contain a substituent and R.sub.2 represents an alkyl group which may contain a substituent, or R.sub.1 and R.sub.2 in combination with each other and with the adjacent nitrogen atom from a ring which may contain a nitrogen atom other than said adjacent nitrogen atom, an oxygen atom, or a substituent, and R.sub.3 represents a cyano group, a carbamoyl group, or a lower alkoxycarbonyl group. The compound exhibits superior cardiotonic activity and vasodilative activity, and thus is effective as a medicine.Type: GrantFiled: September 16, 1988Date of Patent: June 12, 1990Assignee: SS Pharmaceutical Co., Ltd.Inventors: Fujiko Koono, Norimitsu Umehara, Hideaki Matsuda, Tatsuhiko Katori
-
Patent number: 4925953Abstract: Novel imidazole derivatives and their acid adducts are disclosed. The imidazole derivatives are represented by formula: ##STR1## wherein R.sub.1 represents an alkyl group, R.sub.2 represents a hydrogen atom, an alkyl group which may have a substituent, or an aralkyl group which may have a substituent, provided that R.sub.1 and R.sub.2 are not both methyl groups at the same time. They have strong antimicrobial activity, especially against those fungi belonging to the genera Candida, Trichophyton, Microsporum, and Epidermorphyton, as well as against Gram-positive bacteria, and thus are useful as an antimicrobial agent.Type: GrantFiled: November 29, 1988Date of Patent: May 15, 1990Assignee: SS Pharmaceutical Co., Ltd.Inventors: Minoru Tokizawa, Takemitsu Asaoka, Hideaki Matsuda, Tatsuhiko Katori
-
Patent number: 4906665Abstract: Novel hydroxyalkylcysteine derivatives of the following formula (I) and an expectorant comprising the same are disclosed. ##STR1## wherein n represents an integer of 5 to 24. The expectorant is stabile, has little side effects and toxicity, and exhibits an excellent expectorant effect.Type: GrantFiled: June 13, 1989Date of Patent: March 6, 1990Assignee: SS Pharmaceutical Co., Ltd.Inventors: Yoshikuni Itoh, Hiroyuki Mizuno, Chikako Kiyohara, Susumu Sato, Tatsuhiko Katori
-
Patent number: 4904809Abstract: A platinum complex having a superior antitumor activity is disclosed. The platinum complex has a structure represented by the formula: ##STR1## wherein A and B independently represent a lower alkanoyloxy group which may have a halogen atom substituent, or in combination represent a group: ##STR2## wherein R.sub.1 and R.sub.2 independently represent a hydrogen atom, a hydroxyl group, or a lower alkyl group, or in combination with each other and with the adjacent carbon atom a cyclobutane ring, and R.sub.3 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a halogen atom, a sulfo group, or nitro group.Type: GrantFiled: September 16, 1988Date of Patent: February 27, 1990Assignee: SS Pharmaceutical Co., Ltd.Inventors: Koichi Yokoi, Kinichi Mogi, Kazuhiko Irinoda, Hidehiko Kohya, Susumu Sato, Tatsuhiko Katori
-
Patent number: 4876359Abstract: Novel .gamma.-butyrolactone derivatives having strong ACE inhibitory activity are provided. They are represented by the following general formula (I): ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different and mean individually a hydrogen atom or a straight-chain or branched alkyl or cycloalkyl group, or R.sup.1 and R.sup.2 are bonded together to mean an alkylene group having 2-6 carbon atoms, R.sup.3 denotes a hydrogen atom or a lower alkyl, aralkyl, amino lower alkyl or lower alkoxycarbonylamino lower alkyl group, R.sup.4 means a lower alkyl, cycloalkyl or aralkyl group, R.sup.5 means a hydrogen atom or a lower alkyl group, or R.sub.4 and R.sub.5 are bonded together to denote an alkylene group having 2-4 carbon atoms, and R.sup.6 stands for a hydrogen atom or a lower alkyl or aralkyl group; or a pharmacologically acceptable salt thereof.Type: GrantFiled: October 1, 1987Date of Patent: October 24, 1989Assignee: SS Pharmaceutical Co., Ltd.Inventors: Hiroshi Hasegawa, Noriaki Shioiri, Tadashi Narita, Tatsuhiko Katori
-
Patent number: 4866176Abstract: A 8-piperazinyl-1,7-naphthyridine derivative represented by the following formula (I): ##STR1## in which R represents a hydrogen atom, formyl group, acyl group, aroyl group, heteroaroyl group, substituted phenyl group, pyridyl group, aralkyl group or substituted or unsubstituted benzenesulfonyl group; and an acid adduct salt thereof. The compound has excellent antiinflammatory, antiarrhythmic and cardiotonic effects, and thus is useful as an antiinflammatory drug and a medicine for circulatory organs.Type: GrantFiled: August 13, 1987Date of Patent: September 12, 1989Assignee: SS Pharmaceutical Co., Ltd.Inventors: Haruyoshi Honda, Yuko Yoshida, Tadayuki Kouda, Hideaki Matsuda, Tatsuhiko Katori
-
Patent number: 4849512Abstract: Derivatives of 3-acylamino-3-deoxyallose represented by the following formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 may be hydrogen atoms, or R.sup.1 and R.sup.2, and R.sup.3 and R.sup.4 may be in combination an isopropylidene group, R.sup.5 represents a hydrogen atom or alkyl group, and R.sup.6 represents a hydrogen atom or acyl group, are disclosed. One of the typical compound 3-deoxy-3-(3-tetradecanoyloxytetradecanoylamino)-1,2:5,6-di-O-isopropylide ne- .alpha.-D-allofuranose is prepared by reacting 3-tetradecanoyloxytetradecanoic acid and 3-amino-3-deoxy-1,2:5,6-di-O-isopropylidene-.alpha.-D-allofuranose in the presence of N,N'-dicyclohexylcarbodiimide, as a dehydrating agent. The compound has an excellent carcinostatic activity.Type: GrantFiled: April 1, 1988Date of Patent: July 18, 1989Assignee: SS Pharmaceutical Co., Ltd.Inventors: Minoru Tokizawa, Mari Otsuka, Kazuhiko Irinoda, Seiji Ishizeki, Fumio Ishii, Kenichi Kukita, Hideaki Matsuda, Tatsuhiko Katori
-
Patent number: 4814436Abstract: Derivatives of .alpha.,.alpha.-trehalose-6,6'-fatty acid diester having phosphoric ester groups in the molecule which are useful as a carcinostatic agent. One of the derivatives may be prepared by reacting diphenylphosphoryl chloridate with a derivative of 2,3,2',3'-tetra-O-benzyl-.alpha.,.alpha.-trehalose-6,6'-fatty acid diester. Another derivative may be obtained by substituting benzyl groups at 2,3,2',3' positions of trehalose with hydrogen atoms.Type: GrantFiled: December 8, 1986Date of Patent: March 21, 1989Assignee: SS Pharmaceutical Co., Ltd.Inventors: Akihiro Shibata, Hideaki Matsuda, Hidehiko Kohya, Tatsuhiko Katori
-
Patent number: 4740601Abstract: An imidazole derivative having antimicrobial activities against bacteria, fungi, yeast, pathogenic plant fungi and the like represented by the following general formula (I): ##STR1## wherein R.sub.1 means a hydrogen or halogen atom or a lower alkyl group, R.sub.2 denotes a hydrogen atom or an alkyl, alkenyl, haloalkyl or substituted or unsubstituted benzyl group, R.sub.3 stands for a hydrogen or halogen atom, and R.sub.4 is a substituted or unsubstituted benzylthio group, a phenylthio, alkylthio, alkenylthio, furfurylthio, alkoxy or phenoxy group or a halogen atom; or an acid addition salt thereof.Type: GrantFiled: December 15, 1986Date of Patent: April 26, 1988Assignee: SS Pharmaceutical Co., Ltd.Inventors: Masaki Ogawa, Hideaki Matsuda, Takemitsu Asaoka, Junji Oono, Tatsuhiko Katori
-
Patent number: 4728659Abstract: Disclosed herein are aminomethyl derivatives each of which is of the following general formula (I): ##STR1## wherein A represents a group --C.tbd.C-- or --CH.dbd.CH--, Y represents a group ##STR2## (in which R.sub.3 being a lower alkyl or alkoxy group or a halogen atom) or ##STR3## (in which R.sub.4 being a hydrogen atom or R.sub.3), and R.sub.1 and R.sub.2 represent individually a lower alkyl group, with a proviso that Y is other than the group ##STR4## when A means the group --CH.dbd.CH--, their preparation process and platelet aggregation inhibitors containing same.Type: GrantFiled: June 25, 1985Date of Patent: March 1, 1988Assignee: SS Pharmaceutical Co., Ltd.Inventors: Susumu Sato, Tadayuki Kouda, Tatsuhiko Katori
-
Patent number: 4690924Abstract: Certain 1,7-naphthyridine derivatives and their acid addition salts have strong anticholinergic effects, cardiotonic effects, diuretic effects, bronchodilation effects, anti-acetylocholine effects, anti-inflammatory effects, analgesic effects and the like and are hence useful for various diseases such as heart diseases, hypertension, asthma, arthritis, lumbago, toothache, etc.Type: GrantFiled: December 9, 1986Date of Patent: September 1, 1987Assignee: SS Pharmaceutical Co., Ltd.Inventors: Susumu Sato, Haruyoshi Honda, Teruo Koumoto, Kazuo Isomae, Tadayuki Kuraishi, Tatsuhiko Katori
-
Patent number: 4684719Abstract: Disclosed herein are novel .alpha.,.alpha.-trehalose fatty acid diester derivatives useful as carcinostatic substances and surface-activating materials and represented by the general formula (I): ##STR1## wherein R.sup.1 means an alkyl group having 1-21 carbon atoms, R.sup.2 denotes a hydrogen atom or carbobenzoxy group, and R.sup.3 stands for a hydrogen atom or benzyl group. Their preparation processes are also disclosed.Type: GrantFiled: May 15, 1985Date of Patent: August 4, 1987Assignee: SS Pharmaceutical Co., Ltd.Inventors: Yoshihiro Nishikawa, Kimihiro Kanemitsu, Tatsuhiko Katori, Akihiro Shibata, Kenichi Kukita
-
Patent number: 4659710Abstract: Certain 1,7-naphthyridine derivatives and their acid addition salts have strong antiarrhythmic effects, cardiotonic effects, diuretic effects, bronchodilation effects, anti-acetylcholine effects, anti-inflammatory effects, analgesic effects and the like and are hence useful for various diseases such as heart diseases, hypertension, asthma, arthritis, lumbago, toothache, etc.Type: GrantFiled: April 11, 1986Date of Patent: April 21, 1987Assignee: SS Pharmaceutical Co., Ltd.Inventors: Susumu Sato, Haruyoshi Honda, Teruo Koumoto, Kazuo Isomae, Tadayuki Kuraishi, Tatsuhiko Katori